» Articles » PMID: 16944992

The Colorectal Carcinoma Prognosis Factors. Significance of Diagnosis Delay

Overview
Specialty Gastroenterology
Date 2006 Sep 2
PMID 16944992
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: detection of early-stage colorectal carcinoma (CRC)--( Dukes A or B)--provides better survival rates in these patients. Thus, the effectiveness of screening programs in asymptomatic patients or of early diagnosis in symptomatic individuals has been postulated. The aim of this study was to establish whether a delay in diagnosis or other factors are related to CRC stage.

Patients And Methods: a retrospective study was performed on 96 patients with CRC. Age at diagnosis, gender distribution, intestinal disorders, diagnosis delay, primary sign and -regarding CRC- localization, stage (Dukes) and grade of differentiation (well differentiated; non-well differentiated; poorly differentiated) were recorded.

Results: diagnosis delay was 185 +/- 190 days. Patients delay in obtaining a diagnosis was 119 +/- 158 days. In 40% of patients CRC was diagnosed at an early stage (Dukes A or B), and in 13% CRC was poorly differentiated. The only factor with an independent effect on Dukes stage was tumor differentiation (p: 0.0012). Distal location was associated with less advanced tumors without statistical significance (p: 0.156).

Conclusion: based on the presented data, a greater effort regarding screening programs for healthy people seems warranted, as improved survival has been demonstrated when diagnosis delay is reduced, particularly in patients with the highest mean delay.

Citing Articles

Challenges in diagnosing and treating distal common bile duct adenocarcinoma: A case report with literature insights.

Alshwayyat S, Hanifa H, Alshwaiyat Y, Alshwayyat M, Alhussein H, Abu-Naja M Int J Emerg Med. 2025; 18(1):43.

PMID: 40033199 PMC: 11877818. DOI: 10.1186/s12245-025-00859-7.


The effect of time before diagnosis and treatment on colorectal cancer outcomes: systematic review and dose-response meta-analysis.

Drosdowsky A, Lamb K, Karahalios A, Bergin R, Milley K, Boyd L Br J Cancer. 2023; 129(6):993-1006.

PMID: 37528204 PMC: 10491798. DOI: 10.1038/s41416-023-02377-w.


The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.

Kou T, Sha D, Wang F, He T, He X Cell Biochem Biophys. 2020; 79(1):113-121.

PMID: 33151473 DOI: 10.1007/s12013-020-00955-w.


Effect of diagnostic delay on survival in patients with colorectal cancer: a retrospective cohort study.

Pita-Fernandez S, Gonzalez-Saez L, Lopez-Calvino B, Seoane-Pillado T, Rodriguez-Camacho E, Pazos-Sierra A BMC Cancer. 2016; 16:664.

PMID: 27549406 PMC: 4994409. DOI: 10.1186/s12885-016-2717-z.


Postreferral colonoscopy delays in diagnosis of colorectal cancer: a mixed-methods analysis.

Singh H, Khan R, Giardina T, Paul L, Daci K, Gould M Qual Manag Health Care. 2012; 21(4):252-61.

PMID: 23011072 PMC: 3702372. DOI: 10.1097/QMH.0b013e31826d1f28.